Pharmacokinetics of sparfloxacin in patients with renal impairment.
The pharmacokinetics of sparfloxacin were studied in 14 renal failure patients (group I, 7 with creatinine clearance of > 10 to 30 ml/min; and group II, 7 with creatinine clearance of < or = 10 ml/min) after a single oral dose of 400 mg. Plasma and urine samples were collected up to 144 h postdosing...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1994
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284534/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8031038/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.4.733 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
